Biologics
Fayetteville, US · 2 known investors
BiologicsMD develops recombinant fusion proteins targeting parathyroid hormone receptors for hair loss, bone disorders, and oncology treatments. The company's technology uses a dual-domain approach to localize therapeutics to disease sites with minimal off-target effects.
BiotechDeep TechMedical Devices
Founders & leadership
RB
Ramsay BallDirector
RG
Robyn GoforthExecutive Officer
CG
Calvin GoforthDirector, Promoter
RG
Rob GensureExecutive Officer
JD
J. David OwensExecutive Officer, Director
LD
Lynn David KirkpatrickDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements$400KraisedFeb 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- BiologicsMD - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Patented Protein from Fayetteville Firm Treats Bone and Hair Lossarkansasbusiness.com · 2015
- BiologicsMD, Inc. Awards Manufacturing Contract to Cytovance Biologics, Inc. to Expand Development of Breakthrough Osteoporosis Medication | Business Wirebusinesswire.com · 2012
- BiologicsMD of Fayetteville Gets $2.3 Million Contractarkansasbusiness.com · 2011